Apollo Pharmalogistics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 4763.09%
(FY 2023)
- Profit 60241.67%
(FY 2023)
- Ebitda 10939.81%
(FY 2023)
- Net Worth 2284.44%
(FY 2023)
- Total Assets 281.82%
(FY 2023)
About Apollo Pharmalogistics
The Corporate was formerly known as Apollo Proton Therapy Cancer Centre Private Limited. The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Singana Reddy, Subramanian Vridhakasi, and Lodugureddygari Lakshminarayanareddy serve as directors at the Company.
- CIN/LLPIN
U93000TN2018PTC125246
- Company No.
125246
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2018
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Apollo Pharmalogistics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Singana Reddy  | Director | 14-Feb-2022 | Current |
| Subramanian Vridhakasi | Director | 14-Mar-2022 | Current |
| Lodugureddygari Lakshminarayanareddy | Director | 14-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Apollo Pharmalogistics.
Apollo Pharmalogistics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4763.09% increase. The company also saw a substantial improvement in profitability, with a 60241.67% increase in profit. The company's net worth Soared by an impressive increase of 2284.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apollo Pharmalogistics?
In 2023, Apollo Pharmalogistics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spectra Hospital Services Private LimitedActive 25 years 6 daysSingana Reddy and Subramanian Vridhakasi are mutual person
Searchlight Health Private LimitedActive 17 years 5 monthsLodugureddygari Lakshminarayanareddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apollo Pharmalogistics?
Apollo Pharmalogistics has a workforce of 334 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apollo Pharmalogistics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apollo Pharmalogistics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
